/ /

Michelle Dalton
Range of ‘uninterrupted vision’ possible with inlay
Study patients with a near vision inlay implanted under a femtosecond flap achieved extended depth of focus that ranged from +1 to +3 D, said John A. Hovanesian, MD.
Re-esterfied omega-3 fatty acids effective for dry eye
Oral consumption of re-esterfied omega-3 fatty acids once daily for 12 weeks is “an effective treatment for dry eye disease,” said Eric D. Donnenfeld, MD.
When it comes to lamellar surgery, a bevy of options
With the influx of numerous endothelial keratoplasty procedures, only 15% of corneal transplants last year were penetrating keratoplasty (PK), said Donald T.H. Tan, MD, Singapore.
Bean-shaped rings offer capsular support where none exists
Bean-shaped rings can be useful devices for implantation of “bag-in-the-lens in eyes with loose or no capsular support,” said Marie José B. Tassignon, MD, PhD.
Consider phakic IOLs for correcting myopia, surgeon says
Phakic IOL implantation is as potentially viable a means to correct myopia as LASIK/PRK or refractive lens exchange, said Sonia H. Yoo, MD.
Fibrin glue an option when capsular support is lacking
Fixating a posterior chamber IOL using fibrin glue is a “viable option in patients with deficient capsular support,” said Mahipal S. Sachdev, MBBS, MD.
Changing nature of combat brings new set of ocular injuries
When military personnel are injured in combat situations, the primary concern of saving lives supersedes saving sight, said Col. Anthony J. Johnson, MD, Fort Sam Houston, Antonio, TX.
Emerging pandemics require ‘high degree of alertness’
A number of emerging infectious diseases have made recent headlines—most prominently, the Ebola virus outbreak in West Africa—prompting higher levels of vigilance, Paul Tambyah, MD, PhD, Singapore.
Can Schlemm’s canal surgery be glaucoma’s Holy Grail?
Glaucoma surgeons are constantly clamoring for better surgical techniques. Traditional, incisional glaucoma surgery shunts fluid to the subconjunctival space and provides a route for aqueous to leave the eye by bypassing the normal outflow system and avoiding sources of resistance to outflow, said Barbara Smit, MD, PhD.
Tomorrowland: What the future holds in glaucoma therapies
The present method of lowering IOP as a means of preventing optic neuropathy is expanding beyond prostaglandin analogues and beta blockers to include novel therapeutics, such as Rho kinase (ROCK) inhibitors, the adenosine class of drugs, and nitric oxide added to prostaglandins, said John R. Samples, MD.


View Results